Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Cash & Current Investments (2010 - 2026)

Exelixis (EXEL) posted quarterly Cash & Current Investments of $777.2 million for Q2 2026, down 24.64% year-over-year from $1.0 billion in Q2 2025, and down 26.62% quarter-over-quarter from $1.1 billion in Q1 2026.

Analysis

Exelixis (EXEL) Cash & Current Investments (2010 - 2026) Analysis & Trends

Exelixis' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $777.2 million for Q2 2026.

  • In Q2 2026, Cash & Current Investments fell 24.64% year-over-year to $777.2 million; the TTM figure through Apr 2026 stood at $777.2 million (down 24.64% YoY), while the FY2026 annual figure was $1.1 billion, down 4.7% from the prior year.
  • Cash & Current Investments for Q2 2026 stood at $777.2 million, down from $1.1 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $1.6 billion in Q2 2022, with the low at $777.2 million in Q2 2026.
  • The 5-year median for Cash & Current Investments is $1.1 billion (2023), against an average of $1.2 billion.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 32.46% in 2022, then fell 28.68% in 2023.
  • Exelixis' Cash & Current Investments stood at $1.3 billion in 2022, then retreated by 23.93% to $995.3 million in 2023, then advanced by 19.48% to $1.2 billion in 2024, then decreased by 16.87% to $988.5 million in 2025, then slipped by 21.38% to $777.2 million in 2026.
  • Business Quant data shows EXEL's Cash & Current Investments at $777.2 million in Q2 2026, $1.1 billion in Q1 2026, and $988.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 839.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 839.39 Mn
Apr 3, 2026 777.21 Mn
Jan 2, 2026 1.06 Bn
Oct 3, 2025 988.54 Mn
Jul 4, 2025 791.10 Mn
Apr 4, 2025 1.03 Bn
Jan 3, 2025 1.11 Bn
Sep 27, 2024 1.19 Bn
Jun 28, 2024 1.00 Bn
Mar 29, 2024 963.26 Mn
Dec 29, 2023 995.30 Mn
Sep 29, 2023 1.10 Bn
Jun 30, 2023 1.27 Bn
Mar 31, 2023 1.31 Bn
Dec 30, 2022 1.31 Bn
Sep 30, 2022 1.55 Bn
Jul 1, 2022 1.53 Bn
Apr 1, 2022 1.57 Bn
Dec 31, 2021 1.47 Bn
Oct 1, 2021 1.40 Bn